Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07475377 · ClinicalTrials.gov registry record · NA
Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT07475377 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants.
The verdict
NCT07475377, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the time an individual eats each day impacts neurological health in people with multiple sclerosis. The main questions the investigators are asking are: 1. Does meal timing affect biomarkers of neuronal health (neurofilament light chain \[NfL\] and BDNF) and inflammation (IL-6, IL-17, TNF-ɑ) in adults with MS. 2. Does meal timing affect expression of circadian clock genes and genes associated with autophagy in adults with MS. Participants will be instructed to start and stop eating at specific times each day based on their group assignment and their personal schedule. They will respond to prompts sent to them on their smartphone to record the times they start and stop eating each day. As a secondary goal, the study will also explore the feasibility of including translocator protein (TSPO)-PET imaging of neuroinflammation in future clinical trials of TRE in people with MS. To accomplish this, imaging will be completed in a subset of 8 participants at the beginning and end of the study.
Interventions
- BEHAVIORAL Time Restricted Eating
- BEHAVIORAL Unrestricted eating
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07475377
The ClinicalTrials.gov registry entry for NCT07475377 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Time Restricted Eating is the first listed.
NCT07475377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07475377 about?
NCT07475377 is a clinical study titled "Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis". The goal of this clinical trial is to learn if the time an individual eats each day impacts neurological health in people with multiple sclerosis. The main questions the investigators are asking are: 1. Does meal timing affect biomarkers of neuronal health (neurofilament light chain \[NfL\] and BDN...
What is the current status of trial NCT07475377?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2026-07-01. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07475377?
The interventions under investigation include: Time Restricted Eating (BEHAVIORAL), Unrestricted eating (BEHAVIORAL).
Who is sponsoring clinical trial NCT07475377?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.